News
Patients on GLP-1 medications lost about half as much weight as participants did in clinical trials, NYU researchers found.
Glucagon-Like-Peptide-1 Agonists, like Ozempic, have become extremely popular for weight loss. Here are some of the side ...
Study comparing bariatric surgery to GLP-1 medications shows 24% total weight loss from surgery versus 4.7% from injectables, with many patients quitting GLP-1 treatment within a year.
GLP-1 drugs like Ozempic help with weight loss, but how do they stack up against bariatric surgery? A new study breaks it ...
Wellness influencer Janelle Rohner has seen the internet’s criticism after revealing she micro-dosed GLP-1 to lose weight.
She lost 250 pounds and thought her journey was over... but then she discovered something most people don't talk about.
Find out if Novo's GLP-1 patent expiring in Canada is a mistake or a calculated move. Did the firm lose exclusivity over a ...
New research links semaglutide and tirzepatide, which are GLP-1 agonists used to treat type 2 diabetes and aid weight loss, ...
While these new drugs are curbing enthusiasm for eating, they are also having a notable effect on food purchases.
A recent study reveals a surge in the use of GLP-1 medications, such as Ozempic and Wegovy, among younger age groups.
GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...
A bipartisan group of congressional lawmakers is calling on the Trump administration to address the continued sale of illicit, compounded GLP-1 products, warning that consumers may be accessing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results